Fahad Mir Appointed as Business Manager at Getz Pharma

Fahad Mir has embarked on an exciting new chapter as Business Manager (Sales & Marketing) at Getz Pharma, where he is leading the commercialization and growth of oncology brands including Trastuget (Trastuzumab) and Xelotab (Capecitabine) across Pakistan.

With a proven track record in strategic brand leadership, Fahad brings extensive experience from his previous roles at Himmel Pharmaceuticals Pvt Ltd, Getz Pharma, Helix Pharma (Pvt.) Ltd., and Wilson’s Pharmaceuticals. He has successfully launched high-impact oncology and specialty products such as Axitinib, Cabozantinib, Niraparib, Neratinib, Trastuzumab, Etanercept, and Upadacitinib, achieving record-breaking sales milestones and strengthening market access across leading institutions including AKUH, CMH, DUHS, and Shifa International. His expertise spans brand strategy, sales force training, KOL engagement, forecasting, budgeting, and integrated promotional campaigns.

Fahad holds a Bachelor of Pharmacy from St. Patrick’s High School, Karachi, and combines strong scientific knowledge with commercial acumen, making him a valuable asset in driving business growth and improving patient access to innovative therapies.